ASNC-ACC-Letter-to-Congress_Price-Transparency-Legislation_02-01-2024
In February 2024, ASNC and the American College of Cardiology shared with Senate leaders concerns about the implications of Section 4 of S.3458, the Health Care PRICE Transparency Act 2.0, which posed an unnecessary administrative burden on already strained physician practices and would not have resulted in a patient-centric solution to price transparency. Section 4 would likely have impacted the vast majority of physicians, ranging from small family practices to specialists—all of whom provide imaging services in the office setting.
Resource Type
Health Policy Memos
Related Resources
Multisociety Letter Urging End to Immigration Processing Delays for International Medical Graduates
ASNC-AAFP_letter to Rubio-Mullin on IMG delays_04-08-2026
PET Case: Low Radiotracer Activity on Stress
Case summary: This case illustrates the importance of myocardial blood flow quality…
PET Case: Unmasking Ischemia: Dobutamine PET Reveals Ischemia Following Regadenoson Non-Response
Case summary: This case illustrates the importance of recognizing myocardial blood flow…